AP
ASCENDIA PHARMACEUTICALS, INC.
StreetZero Signal 63
About ASCENDIA PHARMACEUTICALS, INC.
Ascendia Pharmaceuticals, Inc. is a specialty CDMO based in North Brunswick, NJ, dedicated to developing and manufacturing enhanced formulations for pre-clinical, clinical-stage drug candidates, and marketed drug products. The company specializes in improving the solubility and bioavailability of poorly water-soluble drugs using its nanotechnology platforms. It formulates products for injectable, oral, and topical routes of administration with three technology platforms including EmulSol®.
LATEST FUNDINGPrivate Placement
$4.1M
Announced 2026-11-06
TOTAL RAISED$10M
IN THE NEWS
- 🔗 Ascendia Pharmaceuticals - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Ascendia Pharmaceuticals - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Ascendia Pharmaceuticals Secures Growth Equity Investment from Signet Healthcare Partners
- 🔗 Ascendia Pharmaceuticals - 2026 Funding Rounds & List of Investors - Tracxn
- 🔗 Ascendia Pharmaceuticals - 2026 Funding Rounds & List of Investors - Tracxn
EMPLOYEES—
FOUNDED2012
HQNorth Brunswick, New Jersey, United States
Industry
Other Health Care
Tags
CDMOSpecialty PharmaFormulationNanotechnology
Investors
Key highlights
- Specialty CDMO focused on solubility and bioavailability enhancement via nanotechnology platforms.
- Raised $4,084,536 in private placement with total funding reported at $10M over multiple rounds.
- Backed by Signet Healthcare Partners as sole disclosed institutional investor.
- Operates platforms for injectable, oral, and topical drug formulations.
Ask StreetZero about ASCENDIA PHARMACEUTICALS, INC.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account